Fz7-21

Fz7-21 Suppliers list
Company Name: Wuxi Zhongkun Biochemical Technology Co., Ltd.  
Tel: 0510-85629785 18013409632;
Email: sales@reading-chemicals.com
Company Name: Creative Peptides   
Tel:
Email: info@creative-peptides.com
Company Name: Shanghai EFE Biological Technology Co., Ltd.  
Tel: 021-65675885 18964387627
Email: info@efebio.com
Company Name: Beijing Solarbio Science & Tecnology Co., Ltd.  
Tel: 17801761073 18101056239
Email: 3193328036@qq.com
Company Name: Chengdu Youngshe Chemical Co., Ltd.  
Tel: +86-17380623303
Email: Caroline@youngshechem.com

Fz7-21 manufacturers

  • Fz7-21
  • Fz7-21 pictures
  • $68.00
  • 2026-07-21
  • CAS:2247635-23-8
  • Purity: 99.80%
  • Supply Ability: 10g
  • Fz7-21
  • Fz7-21 pictures
  • $1.00
  • 2020-03-06
  • CAS:2247635-23-8
  • Min. Order: 1g
  • Purity: ≥98%
Fz7-21 Basic information
Product Name:Fz7-21
Synonyms:Fz7-21;Ac-Leu-Pro-Ser-Asp-Asp-Leu-Glu-Phe-Trp-Cys-His-Val-Met-Tyr-NH2;(Ac)-LPSDDLEFWCHVMY-NH2;lipid-binding groove,FZD7,Wnt,Fz7 21,Wnt–β-catenin,Fz-7-21,conformation,FZD7 CRD,intestinal organoids,Fz7-21,Inhibitor,Fz721,inhibit
CAS:2247635-23-8
MF:C83H114N18O23S2
MW:1796.05
EINECS:
Product Categories:
Mol File:2247635-23-8.mol
Fz7-21 Structure
Fz7-21 Chemical Properties
Boiling point 2088.7±65.0 °C(Predicted)
density 1.358±0.06 g/cm3(Predicted)
pka4.15±0.10(Predicted)
form Solid
color White to off-white
Safety Information
MSDS Information
Fz7-21 Usage And Synthesis
UsesFz7-21 (Ac-LPSDDLEFWCHVMY-NH2) is a potent peptide antagonist of FZD7 receptors , selectively binds to FZD7 CRD subclass and alters the conformation of the CRD and the architecture of its lipid-binding groove. The EC50 values are 58 and 34 nM for human and mouse FZD7 CRD, respectively. Fz7-21 impairs the function of FZD7 in Wnt–β-catenin signalling and stem cell function in intestinal organoids[1][2].
storage-20°C
References[1] Nile AH, et, al. A selective peptide inhibitor of Frizzled 7 receptors disrupts intestinal stem cells. Nat Chem Biol. 2018 Jun;14(6):582-590. DOI:10.1038/s41589-018-0035-2
[2] Larasati Y, et, al. Unlocking the Wnt pathway: Therapeutic potential of selective targeting FZD7 in cancer. Drug Discov Today. 2022 Mar;27(3):777-792. DOI:10.1016/j.drudis.2021.12.008
Fz7-21 Preparation Products And Raw materials
Tag:Fz7-21(2247635-23-8) Related Product Information
N-[(1,1-Dimethylethoxy)carbonyl]-L-methionyl-L-α-aspartylglycyl-L-cysteinyl-L-α-glutamyl-L-leucine IWP-2 NCB-0846 Heparitin, sulfate Adavivint GSK-3BETA INHIBITOR XII